RimWorld's expansions have consistently added ... Thankfully, there are ways to control the risk you take upon yourself, allowing a colony to benefit from the expansion's early offerings without ...

Fidelity Select Biotechnology Portfolio earns an Above Average Process Pillar rating. The main driver of the rating is its parent firm's excellent long-term risk-adjusted performance, as shown by ...

Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...

A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...

An international research team led by the University of California, Irvine has discovered a new type of skeletal tissue that offers great potential for advancing regenerative medicine and tissue ...

Portage Biotech Inc. WESTPORT, Conn., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Portage Biotech, Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a ...

VIR's is expected to report data in January from two phase 1 trials of VIR-5500 and VIR-5818, two T-cell engagers, in various cancer types. JANX recently produced promising data with JANX007 ...

Psycasts are powerful abilities for pawns to survive their cruel world. Learn which Psycasts to prioritize in Rimworld here.

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

They each operate in treatment areas with high demand. Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients need their ...

Now, Novartis has signed a pact with the California biotech aimed at discovering an undisclosed number of new therapeutic targets, according to a Dec. 18 release. The Swiss pharma will pay BioAge ...